Myriad Genetics Aktie
4,05
EUR
+0,13
EUR
+3,24
%
4,62
USD
+0,13
USD
+2,78
%
Myriad Genetics jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Myriad Genetics Aktie Analyse
| 17.03.06 | Myriad Genetics buy | UBS | |
| 15.03.06 | Myriad Genetics buy | First Albany | |
| 10.02.06 | Myriad Genetics overweight | JP Morgan | |
| 09.02.06 | Myriad Genetics strong buy | JMP Securities | |
| 09.02.06 | Myriad Genetics Strong Buy | JMP Securities | |
| 08.02.06 | Myriad Genetics outperform | Piper Jaffray | |
| 05.01.06 | Myriad Genetics | Jaindl & Mautz | |
| 19.12.05 | Myriad Genetics stark kaufen | Jaindl & Mautz | |
|
Werbung
|
|||
| 10.10.05 | Myriad Genetics | Jaindl & Mautz | |
| 25.08.05 | Myriad Genetics buy | Merrill Lynch | |
| 21.06.05 | Myriad Genetics outperform | Piper Jaffray | |
| 16.06.05 | Myriad Genetics outperform | Piper Jaffray | |
Werbung
Werbung